NEW YORK, July 23-Nanosphere said yesterday that it had formed a distribution and development agreement with the Japanese firm Takara Bio.
Under the agreement, Takara will be the exclusive Nanosphere distributor in Asia, and have non-exclusive distribution rights in Europe.
The two companies will also work to develop portable protein and nucleic acid identification systems that combine Nanosphere's DNA probe technology with Takara's gene amplification techniques.
Further, Takara will make an equity investment in Nanosphere.
Specific financial details of the agreement were not disclosed.
Nanosphere is a privately held assay firm based in Northbrook, Ill.
Takara Bio, based in Otsu, Japan, is a biotechnology subsidiary of Takara Holdings.